[The tested combination is recommended. Are 5-alpha reductase inhibitors interchangeable?].
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D001378:Azasteroids / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D004359:Drug Therapy, Combination; D000068538:Dutasteride; D018120:Finasteride / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D013997:Time Factors
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D001378:Azasteroids; D018120:Finasteride; D000068538:Dutasteride